Work

The Conundrum of Disabling Severe Delayed Pressure Urticaria and the Efficacy of Omalizumab

Year: 2023

Type: article

Study design: Case Report

Source: Annals of Allergy Asthma & Immunology

DOI: 10.1016/j.anai.2023.08.396

Authors: C. Rupprecht, S. Relangi, D. Rana, A. Haque, G. Krishnaswamy

Language: English

Topic: Urticaria and Related Conditions

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4388528064

FWCI:

Cites:

Cited by:

Related to: 10